Drupal.behaviors.print = function(context) {window.print();window.close();}>
Vermillion's Q1 Revenues Drop 28 Percent; CEO Page to Leave Firm
May 15, 2012
Vermillion's Q1 Revenues Drop 28 Percent; CEO Page to Leave Firm
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Vermillion's OVA1 Sales Increase 8 Percent in Q1
May 16, 2013 / GenomeWeb Daily News
UPDATE: Vermillion Posts Flat Q3 Revenues
November 13, 2012 / GenomeWeb Daily News
Vermillion Posts 8 Percent Increase in OVA1 Sales, Announces Shift in Commercialization Strategy
May 17, 2013 / ProteoMonitor
GenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the Clinic
May 10, 2013 / ProteoMonitor
Vermillion to Raise up to $31.5M in Equity Financing
May 9, 2013 / GenomeWeb Daily News